<?xml version="1.0" ?><!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st June 2018//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_180601.dtd"><PubmedArticleSet><PubmedArticle>    <MedlineCitation Status="In-Process" Owner="NLM">        <PMID Version="1">30348163</PMID>        <DateRevised>            <Year>2018</Year>            <Month>11</Month>            <Day>14</Day>        </DateRevised>        <Article PubModel="Electronic">            <Journal>                <ISSN IssnType="Electronic">1471-2407</ISSN>                <JournalIssue CitedMedium="Internet">                    <Volume>18</Volume>                    <Issue>1</Issue>                    <PubDate>                        <Year>2018</Year>                        <Month>Oct</Month>                        <Day>22</Day>                    </PubDate>                </JournalIssue>                <Title>BMC cancer</Title>                <ISOAbbreviation>BMC Cancer</ISOAbbreviation>            </Journal>            <ArticleTitle>Receptor activator of nuclear factor kB ligand, osteoprotegerin, and risk of death following a breast cancer diagnosis: results from the EPIC cohort.</ArticleTitle>            <Pagination>                <MedlinePgn>1010</MedlinePgn>            </Pagination>            <ELocationID EIdType="doi" ValidYN="Y">10.1186/s12885-018-4887-3</ELocationID>            <Abstract>                <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Receptor activator of nuclear factor kappa-B (RANK)-signaling is involved in tumor growth and spread in experimental models. Binding of RANK ligand (RANKL) to RANK activates signaling, which is inhibited by osteoprotegerin (OPG). We have previously shown that circulating soluble RANKL (sRANKL) and OPG are associated with breast cancer risk. Here we extend these findings to provide the first data on pre-diagnosis concentrations of sRANKL and OPG and risk of breast cancer-specific and overall mortality after a breast cancer diagnosis.</AbstractText>                <AbstractText Label="METHODS" NlmCategory="METHODS">Two thousand six pre- and postmenopausal women with incident invasive breast cancer (1620 (81%) with ER+ disease) participating in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort were followed-up for mortality. Pre-diagnosis concentrations of sRANKL and OPG were quantified in baseline serum samples using an enzyme-linked immunosorbent assay and electrochemiluminescent assay, respectively. Hazard ratios (HRs) and 95% confidence intervals (CIs) for breast cancer-specific and overall mortality were calculated using Cox proportional hazards regression models.</AbstractText>                <AbstractText Label="RESULTS" NlmCategory="RESULTS">Especially in women with ER+ disease, higher circulating OPG concentrations were associated with higher risk of breast cancer-specific (quintile 5 vs 1 HR 1.77 [CI 1.03, 3.04]; p<sub>trend</sub> 0.10) and overall mortality (q5 vs 1 HR 1.39 [CI 0.94, 2.05]; p<sub>trend</sub> 0.02). sRANKL and the sRANKL/OPG ratio were not associated with mortality following a breast cancer diagnosis.</AbstractText>                <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">High pre-diagnosis endogenous concentrations of OPG, the decoy receptor for RANKL, were associated with increased risk of death after a breast cancer diagnosis, especially in those with ER+ disease. These results need to be confirmed in well-characterized patient cohorts.</AbstractText>            </Abstract>            <AuthorList CompleteYN="Y">                <Author ValidYN="Y">                    <LastName>Sarink</LastName>                    <ForeName>Danja</ForeName>                    <Initials>D</Initials>                    <AffiliationInfo>                        <Affiliation>Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120, Heidelberg, Germany.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Schock</LastName>                    <ForeName>Helena</ForeName>                    <Initials>H</Initials>                    <AffiliationInfo>                        <Affiliation>Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120, Heidelberg, Germany.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Johnson</LastName>                    <ForeName>Theron</ForeName>                    <Initials>T</Initials>                    <AffiliationInfo>                        <Affiliation>Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120, Heidelberg, Germany.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Chang-Claude</LastName>                    <ForeName>Jenny</ForeName>                    <Initials>J</Initials>                    <AffiliationInfo>                        <Affiliation>Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120, Heidelberg, Germany.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Overvad</LastName>                    <ForeName>Kim</ForeName>                    <Initials>K</Initials>                    <AffiliationInfo>                        <Affiliation>Section for Epidemiology, Department of Public Health, Aarhus University, Aarhus, Denmark.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Olsen</LastName>                    <ForeName>Anja</ForeName>                    <Initials>A</Initials>                    <AffiliationInfo>                        <Affiliation>Danish Cancer Society Research Center, Copenhagen, Denmark.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Tjønneland</LastName>                    <ForeName>Anne</ForeName>                    <Initials>A</Initials>                    <AffiliationInfo>                        <Affiliation>Danish Cancer Society Research Center, Copenhagen, Denmark.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Arveux</LastName>                    <ForeName>Patrick</ForeName>                    <Initials>P</Initials>                    <AffiliationInfo>                        <Affiliation>Breast and Gynaecologic Cancer Registry of Côte d'Or, Georges-François Leclerc Comprehensive Cancer Care Centre, Dijon, France.</Affiliation>                    </AffiliationInfo>                    <AffiliationInfo>                        <Affiliation>Université Paris-Saclay, Université Paris-Sud, UVSQ, CESP, INSERM, Villejuif, France.</Affiliation>                    </AffiliationInfo>                    <AffiliationInfo>                        <Affiliation>Gustave Roussy, Villejuif, France.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Fournier</LastName>                    <ForeName>Agnès</ForeName>                    <Initials>A</Initials>                    <AffiliationInfo>                        <Affiliation>Université Paris-Saclay, Université Paris-Sud, UVSQ, CESP, INSERM, Villejuif, France.</Affiliation>                    </AffiliationInfo>                    <AffiliationInfo>                        <Affiliation>Gustave Roussy, Villejuif, France.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Kvaskoff</LastName>                    <ForeName>Marina</ForeName>                    <Initials>M</Initials>                    <AffiliationInfo>                        <Affiliation>Université Paris-Saclay, Université Paris-Sud, UVSQ, CESP, INSERM, Villejuif, France.</Affiliation>                    </AffiliationInfo>                    <AffiliationInfo>                        <Affiliation>Gustave Roussy, Villejuif, France.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Boeing</LastName>                    <ForeName>Heiner</ForeName>                    <Initials>H</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Epidemiology, German Institute of Human Nutrition Potsdam-Rehbruecke, Nuthetal, Germany.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Karakatsani</LastName>                    <ForeName>Anna</ForeName>                    <Initials>A</Initials>                    <AffiliationInfo>                        <Affiliation>Hellenic Health Foundation, Athens, Greece.</Affiliation>                    </AffiliationInfo>                    <AffiliationInfo>                        <Affiliation>2nd Pulmonary Medicine Department, School of Medicine, National and Kapodistrian University of Athens, &quot;ATTIKON&quot; University Hospital, Haidari, Athens, Greece.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Trichopoulou</LastName>                    <ForeName>Antonia</ForeName>                    <Initials>A</Initials>                    <AffiliationInfo>                        <Affiliation>Hellenic Health Foundation, Athens, Greece.</Affiliation>                    </AffiliationInfo>                    <AffiliationInfo>                        <Affiliation>WHO Collaborating Center for Nutrition and Health, Unit of Nutritional Epidemiology and Nutrition in Public Health, Department of Hygiene, Epidemiology and Medical Statistics, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>La Vecchia</LastName>                    <ForeName>Carlo</ForeName>                    <Initials>C</Initials>                    <AffiliationInfo>                        <Affiliation>Hellenic Health Foundation, Athens, Greece.</Affiliation>                    </AffiliationInfo>                    <AffiliationInfo>                        <Affiliation>Department of Clinical Sciences and Community Health, University of Milan, Milan, Italy.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Masala</LastName>                    <ForeName>Giovanna</ForeName>                    <Initials>G</Initials>                    <AffiliationInfo>                        <Affiliation>Cancer Risk Factors and Life-Style Epidemiology Unit, Cancer Research and Prevention Institute - ISP, Florence, Italy.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Agnoli</LastName>                    <ForeName>Claudia</ForeName>                    <Initials>C</Initials>                    <AffiliationInfo>                        <Affiliation>Epidemiology and Prevention Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Panico</LastName>                    <ForeName>Salvatore</ForeName>                    <Initials>S</Initials>                    <AffiliationInfo>                        <Affiliation>Dipartimento di Medicine Clinica e Chirurgia, Federico II University, Naples, Italy.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Tumino</LastName>                    <ForeName>Rosario</ForeName>                    <Initials>R</Initials>                    <AffiliationInfo>                        <Affiliation>Cancer Registry and Histopathology Department, &quot;Civic M.P.Arezzo&quot; Hospital, Azienda Sanitaria Provinciale, Ragusa, Italy.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Sacerdote</LastName>                    <ForeName>Carlotta</ForeName>                    <Initials>C</Initials>                    <AffiliationInfo>                        <Affiliation>Unit of Cancer Epidemiology, Città della Salute e della Scienza University Hospital and Center for Cancer Prevention (CPO), Turin, Italy.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>van Gils</LastName>                    <ForeName>Carla H</ForeName>                    <Initials>CH</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Epidemiology, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, the Netherlands.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Peeters</LastName>                    <ForeName>Petra H M</ForeName>                    <Initials>PHM</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Epidemiology, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, the Netherlands.</Affiliation>                    </AffiliationInfo>                    <AffiliationInfo>                        <Affiliation>MRC-PHE Centre for Environment and Health, Department of Epidemiology and Biostatistics, School of Public Health, Imperial College, London, UK.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Weiderpass</LastName>                    <ForeName>Elisabete</ForeName>                    <Initials>E</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Community Medicine, Faculty of Health Sciences, University of Tromsø, The Arctic University of Norway, Tromsø, Norway.</Affiliation>                    </AffiliationInfo>                    <AffiliationInfo>                        <Affiliation>Department of Research, Cancer Registry of Norway, Institute of Population-Based Cancer Research, Oslo, Norway.</Affiliation>                    </AffiliationInfo>                    <AffiliationInfo>                        <Affiliation>Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.</Affiliation>                    </AffiliationInfo>                    <AffiliationInfo>                        <Affiliation>Genetic Epidemiology Group, Folkhälsan Research Center, Helsinki, Finland.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Agudo</LastName>                    <ForeName>Antonio</ForeName>                    <Initials>A</Initials>                    <AffiliationInfo>                        <Affiliation>Unit of Nutrition and Cancer, Cancer Epidemiology Research Program, Catalan Institute of Oncology-IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Rodríguez-Barranco</LastName>                    <ForeName>Miguel</ForeName>                    <Initials>M</Initials>                    <AffiliationInfo>                        <Affiliation>Escuela Andaluza de Salud Pública. Instituto de Investigación Biosanitaria ibs.GRANADA, Hospitales Universitarios de Granada/Universidad de Granada, Granada, Spain.</Affiliation>                    </AffiliationInfo>                    <AffiliationInfo>                        <Affiliation>CIBER de Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Huerta</LastName>                    <ForeName>José María</ForeName>                    <Initials>JM</Initials>                    <AffiliationInfo>                        <Affiliation>CIBER de Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.</Affiliation>                    </AffiliationInfo>                    <AffiliationInfo>                        <Affiliation>Department of Epidemiology, Murcia Regional Health Council, IMIB-Arrixaca, Murcia, Spain.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Ardanaz</LastName>                    <ForeName>Eva</ForeName>                    <Initials>E</Initials>                    <AffiliationInfo>                        <Affiliation>CIBER de Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.</Affiliation>                    </AffiliationInfo>                    <AffiliationInfo>                        <Affiliation>Navarra Public Health Institute, Pamplona, Spain.</Affiliation>                    </AffiliationInfo>                    <AffiliationInfo>                        <Affiliation>IdiSNA, Navarra Institute for Health Research, Pamplona, Spain.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Gil</LastName>                    <ForeName>Leire</ForeName>                    <Initials>L</Initials>                    <AffiliationInfo>                        <Affiliation>Public Health Division of Gipuzkoa, Biodonostia Health Research Institute, San Sebastian, Spain.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Kaw</LastName>                    <ForeName>Kay Tee</ForeName>                    <Initials>KT</Initials>                    <AffiliationInfo>                        <Affiliation>Cancer Epidemiology Unit, University of Cambridge, Cambridge, UK.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Schmidt</LastName>                    <ForeName>Julie A</ForeName>                    <Initials>JA</Initials>                    <AffiliationInfo>                        <Affiliation>Cancer Epidemiology Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Dossus</LastName>                    <ForeName>Laure</ForeName>                    <Initials>L</Initials>                    <AffiliationInfo>                        <Affiliation>International Agency for Research on Cancer, Lyon, France.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>His</LastName>                    <ForeName>Mathilde</ForeName>                    <Initials>M</Initials>                    <AffiliationInfo>                        <Affiliation>International Agency for Research on Cancer, Lyon, France.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Aune</LastName>                    <ForeName>Dagfinn</ForeName>                    <Initials>D</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Epidemiology and Biostatistics, The School of Public Health, Imperial College London, London, UK.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Riboli</LastName>                    <ForeName>Elio</ForeName>                    <Initials>E</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Epidemiology and Biostatistics, The School of Public Health, Imperial College London, London, UK.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Kaaks</LastName>                    <ForeName>Rudolf</ForeName>                    <Initials>R</Initials>                    <AffiliationInfo>                        <Affiliation>Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120, Heidelberg, Germany.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Fortner</LastName>                    <ForeName>Renée T</ForeName>                    <Initials>RT</Initials>                    <Identifier Source="ORCID">http://orcid.org/0000-0002-1426-8505</Identifier>                    <AffiliationInfo>                        <Affiliation>Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120, Heidelberg, Germany. r.fortner@dkfz.de.</Affiliation>                    </AffiliationInfo>                </Author>            </AuthorList>            <Language>eng</Language>            <GrantList CompleteYN="Y">                <Grant>                    <GrantID>111454</GrantID>                    <Agency>Deutsche Krebshilfe</Agency>                    <Country/>                </Grant>                <Grant>                    <GrantID>MC-IIF-623984</GrantID>                    <Agency>FP7 People: Marie-Curie Actions</Agency>                    <Country/>                </Grant>                <Grant>                    <GrantID>2009-AdG 232997</GrantID>                    <Agency>European Research Council</Agency>                    <Country>International</Country>                </Grant>                <Grant>                    <GrantID>PI13/00061</GrantID>                    <Agency>Health research fund (Spain)</Agency>                    <Country/>                </Grant>                <Grant>                    <GrantID>PI13/01162</GrantID>                    <Agency>Health research fund (Spain)</Agency>                    <Country/>                </Grant>                <Grant>                    <GrantID>14136</GrantID>                    <Agency>Cancer Research UK</Agency>                    <Country>United Kingdom</Country>                </Grant>                <Grant>                    <GrantID>C570/A16491</GrantID>                    <Agency>Cancer Research UK</Agency>                    <Country>United Kingdom</Country>                </Grant>                <Grant>                    <GrantID>C8221/A19170</GrantID>                    <Agency>Cancer Research UK</Agency>                    <Country>United Kingdom</Country>                </Grant>                <Grant>                    <GrantID>1000143</GrantID>                    <Agency>Medical Research Council</Agency>                    <Country>United Kingdom</Country>                </Grant>                <Grant>                    <GrantID>MR/M012190</GrantID>                    <Agency>Medical Research Council</Agency>                    <Country>United Kingdom</Country>                </Grant>            </GrantList>            <PublicationTypeList>                <PublicationType UI="D016428">Journal Article</PublicationType>            </PublicationTypeList>            <ArticleDate DateType="Electronic">                <Year>2018</Year>                <Month>10</Month>                <Day>22</Day>            </ArticleDate>        </Article>        <MedlineJournalInfo>            <Country>England</Country>            <MedlineTA>BMC Cancer</MedlineTA>            <NlmUniqueID>100967800</NlmUniqueID>            <ISSNLinking>1471-2407</ISSNLinking>        </MedlineJournalInfo>        <CommentsCorrectionsList>            <CommentsCorrections RefType="Cites">                <RefSource>BMC Med. 2017 Feb 8;15(1):26</RefSource>                <PMID Version="1">28173834</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Stat Med. 1989 May;8(5):551-61</RefSource>                <PMID Version="1">2657958</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Breast Cancer Res Treat. 2017 Feb;161(3):501-513</RefSource>                <PMID Version="1">27915435</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Oncotarget. 2017 Jan 17;8(3):3811-3825</RefSource>                <PMID Version="1">28002811</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Breast Cancer Res. 2010;12(5):R75</RefSource>                <PMID Version="1">20863372</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Mol Ther. 2008 May;16(5):871-8</RefSource>                <PMID Version="1">18388919</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer Res. 2011 Sep 1;71(17):5728-38</RefSource>                <PMID Version="1">21734015</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Nature. 2010 Nov 4;468(7320):98-102</RefSource>                <PMID Version="1">20881962</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Mol Cancer. 2015 Jun 10;14:117</RefSource>                <PMID Version="1">26054853</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer Epidemiol Biomarkers Prev. 1996 Nov;5(11):917-22</RefSource>                <PMID Version="1">8922301</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Eur J Epidemiol. 2015 Mar;30(3):219-30</RefSource>                <PMID Version="1">25446307</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Int J Cancer. 2015 Aug 15;137(4):968-77</RefSource>                <PMID Version="1">25603921</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Public Health Nutr. 2002 Dec;5(6B):1113-24</RefSource>                <PMID Version="1">12639222</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>BMC Cancer. 2017 Apr 18;17(1):280</RefSource>                <PMID Version="1">28420351</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Oncol Rep. 2017 Apr;37(4):2057-2062</RefSource>                <PMID Version="1">28260080</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer Res. 2017 Feb 1;77(3):595-600</RefSource>                <PMID Version="1">28104682</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Lancet. 2015 Aug 1;386(9992):433-43</RefSource>                <PMID Version="1">26040499</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Mol Oncol. 2014 Oct;8(7):1196-207</RefSource>                <PMID Version="1">24785095</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Clin Oncol. 2012 Jul 20;30(21):2601-8</RefSource>                <PMID Version="1">22711854</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Breast Cancer Res Treat. 2012 Oct;135(3):771-80</RefSource>                <PMID Version="1">22926264</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer Res. 2013 Aug 1;73(15):4810-9</RefSource>                <PMID Version="1">23783576</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Oncotarget. 2016 Dec 27;7(52):86687-86694</RefSource>                <PMID Version="1">27893411</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer Epidemiol Biomarkers Prev. 2006 May;15(5):972-8</RefSource>                <PMID Version="1">16702379</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Nature. 2010 Nov 4;468(7320):103-7</RefSource>                <PMID Version="1">20881963</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>PLoS One. 2011 Apr 29;6(4):e19234</RefSource>                <PMID Version="1">21559440</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Mol Cell Biol. 2007 Feb;27(4):1442-54</RefSource>                <PMID Version="1">17145767</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Breast Cancer Res. 2015 Feb 21;17:24</RefSource>                <PMID Version="1">25849336</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Surg Oncol. 2014 Dec;110(7):807-12</RefSource>                <PMID Version="1">25111682</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Nature. 2010 Jun 10;465(7299):803-7</RefSource>                <PMID Version="1">20445538</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer Prev Res (Phila). 2017 Sep;10(9):525-534</RefSource>                <PMID Version="1">28701332</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Anticancer Res. 2013 Jan;33(1):199-206</RefSource>                <PMID Version="1">23267146</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Acta Oncol. 2007;46(2):221-9</RefSource>                <PMID Version="1">17453373</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Breast Cancer Res Treat. 2009 Jan;113(2):217-30</RefSource>                <PMID Version="1">18266105</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Ann Oncol. 2014 Jul;25(7):1422-8</RefSource>                <PMID Version="1">24718887</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Breast Cancer Res Treat. 2017 Jul;164(1):57-67</RefSource>                <PMID Version="1">28417335</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Nature. 2010 Jun 10;465(7299):798-802</RefSource>                <PMID Version="1">20383121</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Int J Oncol. 2011 Jul;39(1):255-61</RefSource>                <PMID Version="1">21491082</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Endocr Relat Cancer. 2006 Jun;13(2):279-92</RefSource>                <PMID Version="1">16728564</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Ann Oncol. 1992 Dec;3(10):783-91</RefSource>                <PMID Version="1">1286041</PMID>            </CommentsCorrections>        </CommentsCorrectionsList>        <KeywordList Owner="NOTNLM">            <Keyword MajorTopicYN="N">Breast cancer</Keyword>            <Keyword MajorTopicYN="N">Epidemiology</Keyword>            <Keyword MajorTopicYN="N">Reproductive, hormonal, and related factors</Keyword>            <Keyword MajorTopicYN="N">Serum biomarkers of endogenous exposures</Keyword>        </KeywordList>    </MedlineCitation>    <PubmedData>        <History>            <PubMedPubDate PubStatus="received">                <Year>2018</Year>                <Month>03</Month>                <Day>07</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="accepted">                <Year>2018</Year>                <Month>10</Month>                <Day>02</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="entrez">                <Year>2018</Year>                <Month>10</Month>                <Day>24</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="pubmed">                <Year>2018</Year>                <Month>10</Month>                <Day>24</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="medline">                <Year>2018</Year>                <Month>10</Month>                <Day>24</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>        </History>        <PublicationStatus>epublish</PublicationStatus>        <ArticleIdList>            <ArticleId IdType="pubmed">30348163</ArticleId>            <ArticleId IdType="doi">10.1186/s12885-018-4887-3</ArticleId>            <ArticleId IdType="pii">10.1186/s12885-018-4887-3</ArticleId>            <ArticleId IdType="pmc">PMC6196438</ArticleId>        </ArticleIdList>    </PubmedData></PubmedArticle></PubmedArticleSet>